Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2388]

AACR 2021: Combining dabrafenib and trametinib to treat BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG) shows significant antitumour activity

AACR 2021: Combining dabrafenib and trametinib to treat BRAF V600E-mutant high-grade (HGG) and low-grade glioma...

AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of immune cells

AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of...

Genes and immune cells predict immunotherapy success in bladder cancer

Genes and immune cells predict immunotherapy success in bladder cancer

Blocking a protein could help overcome cancer resistance to PARP inhibitors

Blocking a protein could help overcome cancer resistance to PARP inhibitors

Low-calorie diet and mild exercise improve survival for young people with leukaemia

Low-calorie diet and mild exercise improve survival for young people with leukaemia

FDA approves isatuximab-irfc for multiple myeloma

FDA approves isatuximab-irfc for multiple myeloma

Discovery may explain high risk of leukaemia in children with Down syndrome

Discovery may explain high risk of leukaemia in children with Down syndrome

FDA approves idecabtagene vicleucel for multiple myeloma

FDA approves idecabtagene vicleucel for multiple myeloma

AI used in battle against asbestos-linked cancer

AI used in battle against asbestos-linked cancer

Forty-three percent of melanoma patients have chronic complications from immunotherapies

Forty-three percent of melanoma patients have chronic complications from immunotherapies

More from ecancer